EUVIMED · CrossrefZeitschrift
The Lancet Rheumatology
ISSN 2665-9913 · Elsevier BV
Neueste Artikel
Effect of ethnicity on response to treatment escalation in patients with systemic lupus erythematosus from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a longitudinal cohort study
The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease
Efficacy and safety of obinutuzumab β in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study
Redefining long-term success in systemic sclerosis
Addressing the urgent need for clinical trials in chronic non-bacterial osteomyelitis
Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional study
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial
Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
Towards global clinical practice guidelines for the management of non-specific low back pain in primary care: a review of current guideline recommendations and how they have changed over the last 30 years
Worldwide trends in hyperuricaemia from 2000 to 2023: a systematic review and modelling analysis
Glucocorticoid treatment in patients with inflammatory rheumatic diseases: current practice and open questions
Patient outcomes from implementing a shared decision-making aid for systemic lupus erythematosus: a prospective implementation study
Strengthening patient and public involvement in digital health innovation: reflective analysis of the development and real-world testing of the MyRA application
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study
Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial
Time to lift the moratorium on IL-23 inhibitors for axial psoriatic arthritis
Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study
IgG4-related disease in the Japanese population: a whole-genome sequencing study
Intensive biological DMARD-first strategy versus standard step-up care in psoriatic arthritis (STAMP): 1-year results from a multicentre, open-label, randomised controlled trial comparing two treat-to-target strategies
The relationship between clinical disease activity, synovial inflammatory profile, and treatment response in rheumatoid arthritis
The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA
Synovial immunopathology in psoriatic arthritis: cellular and molecular insights
Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study
Personalised gait retraining for medial compartment knee osteoarthritis: a randomised controlled trial
Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for prevention
Long-term effectiveness of non-surgical interventions for chronic low back pain: a systematic review and meta-analysis
Towards precision medicine in antiphospholipid syndrome
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study
EUVIMED